UC launches 'REVIVE' clinical trial to test treatment for abdominal injury
Researchers at the University of Cincinnati are launching a clinical study for ResQFoam™, a new device for the treatment of life-threatening internal bleeding in the abdomen. UC Medical Center is one of a handful of Level I Trauma Centers in the United States selected to participate in the multicenter study.
Related Stories
A partnership to end pancreatic cancer
December 19, 2025
Since 2010, BSI Engineering has raised more than $1.2 million for pancreatic cancer research at the University of Cincinnati Cancer Center in honor of a friend and inspiration to BSI’s founders, Bryan Speicher.
Broad co-opportunities
December 18, 2025
Sakura Adachi exemplifies the Bearcat spirit: she works hard, she gives back and she takes full advantage of the opportunities the University of Cincinnati offers.
UC medical students explore ChatGPT’s ability to support qualitative research
December 18, 2025
Newly published research in the journal Medical Science Educator highlights University of Cincinnati College of Medicine student-led work in medical education and examines how artificial intelligence can assist with qualitative research.